Charalabos‐Markos Dintsios
Impact in
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Environmental Valuation
- Healthcare Policy and Management
- Medical Laboratory Technology top 10%
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 30
- Pharmaceutical Economics and Policy 6
- Economic and Financial Impacts of Cancer 2
-
- Health and Medical Studies 7
- Co-authors
- Andreas Gerber (8 shared papers)Jörg Ruof (11 shared papers)Maarten J. IJzerman (3 shared papers)Jeannette G. van Manen (3 shared papers)Marion Danner (3 shared papers)Friedrich Wilhelm Schwartz (5 shared papers)J.-Matthias Graf von der Schulenburg (2 shared papers)Hilda Bastian (1 shared paper)
- Journals
- Value in Health (7 papers)PharmacoEconomics (4 papers)The European Journal of Health Economics (4 papers)International Journal of Technology Assessment in Health Care (4 papers)Patient (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Charalabos‐Markos Dintsios
57 papers receiving 790 citations
Peers
Comparison fields: 5 of 96
- Economics and Econometrics 367
- Medical Laboratory Technology 8
- General Health Professions 110
- Management Science and Operations Research 41
- Pediatrics, Perinatology and Child Health 53
Countries citing papers authored by Charalabos‐Markos Dintsios
This map shows the geographic impact of Charalabos‐Markos Dintsios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charalabos‐Markos Dintsios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charalabos‐Markos Dintsios more than expected).
Fields of papers citing papers by Charalabos‐Markos Dintsios
This network shows the impact of papers produced by Charalabos‐Markos Dintsios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charalabos‐Markos Dintsios. The network helps show where Charalabos‐Markos Dintsios may publish in the future.
Co-authors
The 25 scholars most cited alongside Charalabos‐Markos Dintsios, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 140 | |
| 2 | 2013 | 68 | |
| 3 | 2012 | 49 | |
| 4 | 2016 | 48 | |
| 5 | 2012 | 46 | |
| 6 | 2010 | 40 | |
| 7 | 2017 | 33 | |
| 8 | 2011 | 29 | |
| 9 | 2015 | 26 | |
| 10 | 2014 | 22 | |
| 11 | 2016 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2020 | 17 | |
| 14 | 2017 | 16 | |
| 15 | 2016 | 16 | |
| 16 | 2015 | 16 | |
| 17 | 2014 | 15 | |
| 18 | 2020 | 12 | |
| 19 | 2014 | 12 | |
| 20 | 2018 | 12 |
About Charalabos‐Markos Dintsios
Charalabos‐Markos Dintsios is a scholar working on Economics and Econometrics, General Health Professions, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Surgery, having authored 66 papers that have together received 826 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Pharmaceutical studies and practices (7 papers), Health and Medical Studies (7 papers), Pharmaceutical Economics and Policy (6 papers), Medical and Health Sciences Research (3 papers), Clinical practice guidelines implementation (3 papers), Economic and Financial Impacts of Cancer (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Economics and Econometrics (367 citations), Medical Laboratory Technology (8 citations), General Health Professions (110 citations), Management Science and Operations Research (41 citations) and Pediatrics, Perinatology and Child Health (53 citations). Charalabos‐Markos Dintsios has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas Gerber, Jörg Ruof, Maarten J. IJzerman, Jeannette G. van Manen, Marion Danner, Friedrich Wilhelm Schwartz, J.-Matthias Graf von der Schulenburg, Hilda Bastian, J. Marjan Hummel and Afschin Gandjour. Their work appears in journals such as Value in Health, PharmacoEconomics, The European Journal of Health Economics, International Journal of Technology Assessment in Health Care and Patient.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.